2023. Transthyretin Silencing Therapies and the Cardiology Clinic: Selection, Cost and the Diagnostic Bottleneck Upstream. Journal of Heart and Cardiovascular Science. 4, 1 (Nov. 2023), 1–4. DOI:https://doi.org/10.5281/zenodo.22345291.